about
Endothelial PFKFB3 plays a critical role in angiogenesis.Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity?Endothelial cell metabolism: parallels and divergences with cancer cell metabolismA competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.Endothelial cell metabolism in normal and diseased vasculature.Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in miceActivation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effectsCombination of glycolysis inhibition with chemotherapy results in an antitumor immune response.In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer modelsPreclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neckDeoxyglucose prevents neurodegeneration in culture by eliminating microglia.The wonders of 2-deoxy-D-glucose.Metabolism of stromal and immune cells in health and disease.2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation.Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting.Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis.Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.Cellular effects of fluorodeoxyglucose: Global changes in the lipidome and alteration in intracellular transport.Metabolic Regulation of Angiogenesis in Diabetes and Aging.Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors.Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.Single cell cloning generates lung endothelial colonies with conserved growth, angiogenic, and bioenergetic characteristics.How Endothelial Cells Adapt Their Metabolism to Form Vessels in Tumors.Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis.Endothelial Cell Metabolism.Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.2-Deoxy Glucose Modulates Expression and Biological Activity of VEGF in a SIRT-1 Dependent Mechanism.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in CancerEndothelial Cell Metabolism in Atherosclerosis
P2860
Q33997821-696E22A9-258A-44F9-9402-C68EBC7F5D6DQ34063250-7ACF8442-A93D-4B1E-9CF9-CBFAC31008E9Q34228247-7E26C6F8-E679-4B6F-A4A7-6E7D6CA95FB0Q34808641-11899AF3-0259-41C5-AC5B-266DE7722510Q35234625-664003E9-BB61-4802-A62D-D2FE5E36185BQ36061450-1E5A72FE-335D-4857-9F0E-75BE8A1EDACBQ36175385-AB27173E-C2D3-4B61-A60F-F554F22EFD6CQ36364238-06CA8764-6FFC-47F9-92FF-BF5387A01DCCQ36391616-98599F92-8848-4411-A384-868BB4FD5FC1Q36471376-3E4B6C07-10F4-4AEA-B932-46E6FB5AEF70Q37629550-E2D4E736-1B69-487E-8BBF-4045087F62DFQ37672599-0171638F-16C4-4087-B15F-12EAF80F8E2FQ37703166-FC79F523-CAF1-4F81-B843-564336F8278CQ38191881-0778A7DB-C1C8-417E-AE0B-9EB0A61A15FDQ38227775-30A01B16-189A-4685-B170-20BA62CA7174Q38324927-50E00EBA-49A2-4B3F-83CD-2BA536D27CC5Q38562159-D484DB32-5024-4EDF-A354-F97382E48170Q38739625-01219744-F49C-467B-B9F1-C67B6956AD4DQ38792925-B5B29528-D627-4B66-BE60-317BBDE94F7BQ39201102-06D77E5D-B64D-47E5-A84F-B626601213E9Q39373990-668051C9-604D-4D85-8617-EE0EDB842F8FQ39661367-536A1691-6139-4223-8CA3-E350AFA3060DQ42027824-04B8688D-DCE9-4334-96E1-00252C66268BQ42594048-A0A067E0-5E3F-44CA-BC23-204C77779453Q47133004-F971B8F3-D2EF-4B57-83BE-366336F98213Q47363250-324384C2-DEC8-4F3B-970F-F897E6462E0EQ48333797-FEAD0594-7509-4E78-A658-9F6420076EF3Q49787990-D0288EFC-C0F7-4531-93CB-E6D07B41E9A7Q50428793-46C35F31-5C00-4398-BDD6-359C9335D879Q51702796-8ACDD0A7-6D9A-4EC5-9D54-78386D97AF4CQ55254924-FBB92F58-9A85-4AFD-9CEB-C32F493F1091Q58750618-85A5CC90-41AA-4CBD-AB6F-584C3D0F16F8Q58797353-9F7EA738-3108-4E77-8ACB-69E3CB40BB9C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antiangiogenic activity of 2-deoxy-D-glucose.
@ast
Antiangiogenic activity of 2-deoxy-D-glucose.
@en
type
label
Antiangiogenic activity of 2-deoxy-D-glucose.
@ast
Antiangiogenic activity of 2-deoxy-D-glucose.
@en
prefLabel
Antiangiogenic activity of 2-deoxy-D-glucose.
@ast
Antiangiogenic activity of 2-deoxy-D-glucose.
@en
P2093
P2860
P1433
P1476
Antiangiogenic activity of 2-deoxy-D-glucose.
@en
P2093
Jaclyn W Railsback
Jaime R Merchan
Krisztina Kovács
Mark A Lehrman
Metin Kurtoglu
Ningguo Gao
Theodore J Lampidis
Timothy G Murray
Yolanda Piña
P2860
P304
P356
10.1371/JOURNAL.PONE.0013699
P407
P577
2010-10-27T00:00:00Z